Toxmatch-A chemical classification and activity prediction tool based on similarity measures

Institute for Health and Consumer Protection, Joint Research Centre-European Commission, 21027 Ispra (VA), Italy.
Regulatory Toxicology and Pharmacology (Impact Factor: 2.03). 08/2008; 52(2):77-84. DOI: 10.1016/j.yrtph.2008.05.012
Source: PubMed


Chemical similarity forms the underlying basis for the development of (Quantitative) Structure-Activity Relationships ((Q)SARs), expert systems and chemical groupings. Recently a new software tool to facilitate chemical similarity calculations named Toxmatch was developed. Toxmatch encodes a number of similarity indices to help in the systematic development of chemical groupings, including endpoint specific groupings and read-across, and the comparison of model training and test sets. Two rule-based classification schemes were additionally implemented, namely: the Verhaar scheme for assigning mode of action for aquatic toxicants and the BfR rulebase for skin irritation and corrosion. In this study, a variety of different descriptor-based similarity indices were used to evaluate and compare the BfR training set with respect to its test set. The descriptors utilised in this comparison were the same as those used to derive the original BfR rules i.e. the descriptors selected were relevant for skin irritation/corrosion. The Euclidean distance index was found to be the most predictive of the indices in assessing the performance of the rules.

1 Follower
13 Reads
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: This article provides an overview of the use of computational methods in chemicals hazard and risk assessment under the Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH) legislation. The key aspects of the REACH guidance on the assessment of chemicals are discussed that treat the possible stepwise (tiered) approach combining multiple computational methods in assessing chemicals. Several publicly accessible software tools for the computer-based estimation of chemical hazard, developed by the European Commission's Joint Research Centre (JRC), are described.
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Although inappropriate pharmacokinetic properties were a major cause of attrition in the 1990s, safety issues are recognized as today's single largest cause of drug candidate failure. It is expected that the right balance of in vivo, in vitro and computational toxicology predictions applied as early as possible in the discovery process will help to reduce the number of safety issues. This review focuses on recent developments in computational toxicology. Direct modeling of toxic endpoints has been deceiving and hampered the wide acceptance of computer predictions. The current trend is to make simpler predictions, closer to the mechanism of action, and to follow them up with in vitro or in vivo assays as appropriate.
    Drug discovery today 10/2009; 15(1-2):16-22. DOI:10.1016/j.drudis.2009.09.010 · 6.69 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Animal testing is still compulsory worldwide, for the approval of drugs and chemicals produced in large quantities. Computer-assisted (in silico) technologies are considered to be efficient alternatives to in vivo experiments, and are therefore endorsed by many regulatory agencies, e.g. for use in the European REACH initiative. Advantages of in silico methods include: the possible study of hypothetical compounds; their low cost; and the fact that such virtual experiments are typically based on human data, thus making the question of interspecies transferability obsolete. Since the mid-1990s, computer-based technologies have become an indispensable tool in drug discovery - used primarily to identify small molecules displaying a stereospecific and selective binding to a regulatory macromolecule. Since toxic effects are still responsible for some 20% of the late-stage failures, there is a continuing need for in silico concepts which can be used to estimate a compound's ADMET (adsorption, distribution, metabolism, elimination, toxicity) properties - in particular, toxicity. The aim of this paper is to provide an insight into computational technologies that allow for the prediction of toxic effects triggered by pharmaceuticals. As most adverse and toxic effects are mediated by unwanted interactions with macromolecules involved in biological regulatory systems, we have focused on methodologies that are based on three-dimensional models of small molecules binding to such entities, and discuss the results at the molecular level.
    Alternatives to laboratory animals: ATLA 11/2009; 37(5):477-96. · 1.59 Impact Factor
Show more